Whitehawk Therapeutics, Inc. (3350)
Market Closed
17 Jul, 20:00
XDUS 
€
3. 40
+0.1
+3.0303%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 3.3
Previous Close Want to track 3350 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Whitehawk Therapeutics, Inc. (3350) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 1.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 47.15M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 30
Average volume (90 days) 17
Price summary
52-Week low 1.33
52-Week high 4.54
Beta -
50-Day moving average 3.19
200-Day moving average 2.25
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.89%
Operating margin -2.88%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.15%
Income Statement
Revenue (ttm) 7.14M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) 6.38M
EBITDA -
Net income to common (ttm) -20.6M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 10.26%
Book value per share (mrq) 1.97
Cash Flow
Cash flow statement -12.13M
Levered free cash flow (LFCF) -20.6M
